SHMT2 and Huntington disease: The modeling predictions improved most when the genes serine hydroxymethyltransferase 2 (Shmt2) (or other upregulated genes in the same pathway) (r = 0.92) or ATP citrate lyase (Acly) (r = 0.96) were considered for HD conditions.